Correlation Between Science In and International Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Science In and International Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Science In and International Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Science in Sport and International Biotechnology Trust, you can compare the effects of market volatilities on Science In and International Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Science In with a short position of International Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Science In and International Biotechnology.

Diversification Opportunities for Science In and International Biotechnology

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Science and International is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Science in Sport and International Biotechnology Tr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Biotechnology and Science In is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Science in Sport are associated (or correlated) with International Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Biotechnology has no effect on the direction of Science In i.e., Science In and International Biotechnology go up and down completely randomly.

Pair Corralation between Science In and International Biotechnology

Assuming the 90 days trading horizon Science in Sport is expected to under-perform the International Biotechnology. In addition to that, Science In is 1.06 times more volatile than International Biotechnology Trust. It trades about -0.31 of its total potential returns per unit of risk. International Biotechnology Trust is currently generating about 0.09 per unit of volatility. If you would invest  68,400  in International Biotechnology Trust on October 21, 2024 and sell it today you would earn a total of  1,000.00  from holding International Biotechnology Trust or generate 1.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Science in Sport  vs.  International Biotechnology Tr

 Performance 
       Timeline  
Science in Sport 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Science in Sport has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Science In is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
International Biotechnology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in International Biotechnology Trust are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, International Biotechnology is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Science In and International Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Science In and International Biotechnology

The main advantage of trading using opposite Science In and International Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Science In position performs unexpectedly, International Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Biotechnology will offset losses from the drop in International Biotechnology's long position.
The idea behind Science in Sport and International Biotechnology Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance